Limin Xia

机构：National Clinical Research Center for Digestive Diseases, Xijing Hospital, Tongji Hospital, Huazhong University of Science and Technology, Air Force Medical University · ORCID：0000-0002-6327-6034

发表论文 267 篇 · 总被引 6763 次 · h-index 48

代表论文

• Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside (2024 · Experimental Hematology and Oncology · 被引 101)
• Cancer stem cells and niches: challenges in immunotherapy resistance (2025 · Molecular Cancer · 被引 86)
• Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti–PD-1 resistance in hepatocellular carcinoma (2025 · Science Immunology · 被引 40)
• Lactate and lactylation in cancer: drivers of immune suppression and microenvironmental reprogramming (2025 · Experimental Hematology and Oncology · 被引 27)
• E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression (2025 · Gut · 被引 27)
• MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation (2025 · Clinical and Molecular Hepatology · 被引 13)